As a global leading Contract Development and Manufacturing Organization (CDMO) for Cell and Gene therapy products, Minaris Regenerative Medicine has been offering our clients high value clinical and commercial manufacturing services, development solutions, and technologies for more than 20 years.
Experience the remarkable expansion of our Allendale, New Jersey facilities, showcasing our unwavering success in delivering exceptional clinical and commercial manufacturing for over two decades. Witness the stunning transformation with expansive spaces, cutting-edge design, and state-of-the-art clean rooms and advanced analytical labs. Join forces with us today and seize the opportunity for boundless growth and innovation!
Our expert team will be in attendance at multiple industry events.
Join us at the forthcoming Phacilitate Advanced Therapies Week set to take place from January 16 to 19, 2024, in Miami, Florida.
Visit us at Booth #731 and let's discuss how to collaborate on creating future cell therapy miracles together!
What are the benefits of utilizing 3D bioreactors in your allogeneic therapy product?
Our experts have established efficient large-scale cell product processes using 3D bioreactors to expand adherent and non-adherent cells, allowing our team to design service packages and tailor-made solutions for your specific manufacturing needs.
With a track record of over 100 successful technology transfers and serving clinical manufacturing programs for more than 180 clients, our unparalleled knowledge and expertise set us apart. Discover how we can be a valuable partner to your therapeutic program.
At Minaris, we are experts for development, clinical, and commercial manufacturing of cell and gene therapies. Together with our partners, we have a vision of creating future cell therapy miracles. This allows us to constantly push the boundaries of medicine to serve patients in need. Watch our video to learn more about how we achieve this.
